Hengrui Pharma shares rise as Novo Nordisk signs $2.6 billion drug deal
We haven't written up this one. Investing.com has the full story — the link below goes straight to it.
Also reported by 1 other outlet
- Novo Nordisk strikes $2.6B obesity drug deal with China's Hengrui seekingalpha.com